In a 7,12-dimethylbenz[a]anthracene (DMBA)-induced animal tumor model, fucoidan suppresses breast cancer cell-xenografted tumor growth by inhibiting PI3K/AKT/GSK3β signaling [138]. Here, AKT1 is linked to breast cancer.